Oska Wellness, a technology company committed to developing consumer health and wellness products, announced today that the company will donate $10.00 for each Oska Pulse sold to the National Fibromyalgia & Chronic Pain Association during "Pain Awareness Month," September 1 – 30.
TARIS, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, today announced positive preliminary safety and efficacy data from its clinical study of TAR-302 for the treatment of patients with idiopathic overactive bladder (OAB) refractory to oral therapy.
A free and informative new guide, How to Pick a Partner to Manage Your Intensivist Services, offers the 20 must-ask questions hospitals should pose to every candidate—along with the ideal answers—to determine the most qualified partner to manage their intensivist services.
Late-breaking data published and presented today confirm that the non-invasive HeartFlow® FFRct Analysis enables physicians to effectively differentiate patients in need of coronary stenting or bypass surgery from those who can be managed with medications alone.
Atrium Health's President and CEO, Gene Woods, has been honored as one of 2018's 100 Most Influential People in Healthcare by Modern Healthcare, being named in the top 25 of the most significant innovators, trailblazers and thought-leaders across the healthcare field.
MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska.
The AIDS Healthcare Foundation (AHF) launched its latest outdoor advertising and awareness campaigns with new billboards and bus bench ads placed throughout Southern California.
GN Hearing today unveils the world’s first Premium-Plus hearing aid: ReSound LiNX Quattro™, designed for people who want the very best that technology has to offer and desire a brilliant sound experience with great speech intelligibility even in noisy situations.
Boston Scientific Corporation announced it has recently closed its acquisition of Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel® Cerebral Embolic Protection System, the only device cleared to protect patients against the risk of stroke in transcatheter aortic valve replacement (TAVR) procedures.
The mental health watchdog Citizens Commission on Human Rights (CCHR) International announced that a ban of electroshock treatment — the practice of up to 460 volts of electricity to the brain to "treat mental disorder" — should be imminent in light of increasing reports of patients being damaged and deaths.